Lv2
180 积分 2024-07-11 加入
RIPTACs for Precision Cancer Therapy: A Novel Modality with the Inspiration of HLD-0915 as the First Candidate in Clinical Trials
11天前
已完结
RIPTACs: A groundbreaking approach to drug discovery
11天前
已完结
Design, Synthesis, and Activity Evaluation of Novel Nucleosides as ADAR1 Inhibitor for the Treatment of Prostate Cancer
12天前
已完结
RNA editing underlies genetic risk of common inflammatory diseases
12天前
已完结
Targeting ADAR1 with a Novel Small-Molecule for the Treatment of Prostate Cancer
12天前
已完结
The Carbene Chemistry of N-Sulfonyl Hydrazones: The Past, Present, and Future
18天前
已完结
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers
2个月前
已完结
Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development
2个月前
已完结
Discovery of the Clinical Candidate Sonrotoclax (BGB-11417), a Highly Potent and Selective Inhibitor for Both WT and G101V Mutant Bcl-2
3个月前
已完结
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice
3个月前
已完结
皖公网安备34019202002308
